
Evaluation of Provider vs. Patient Mediated Cascade Genetic Testing of First-Degree Relatives of Patients With Newly Diagnosed Colorectal Cancer
Short Title: A212101
Enrollment Status: Recruiting
NCT #: NCT07143487
Specialty Area: Oncology
Condition Studied: Newly-Diagnosed Colorectal Cancer
Age Groups: Adult; Older Adult
Phase: Not Applicable
Study Information
Summary / Purpose
This clinical trial compares patient (proband)-mediated communication to provider-mediated communication for improving genetic testing in first-degree relatives of patients with newly diagnosed colorectal cancer.
Who Can Participate
- Adults 18+ years of age
- Newly diagnosed primary colorectal adenocarcinoma, Stage I to IV
- Have not received germline testing in the 2 years prior to enrollment or known hereditary colon cancer syndromes
- Must have at least 2 living first-degree relatives
- No known diagnosis of dementia or cognitive impairment
What's Involved
- Pre-test genetic education
- Genetic testing
- Sharing your cancer diagnosis with your first-degree relatives (FDRs)
- Providing the names and phone numbers of at least two of your living FDRs who are age 18 or older
- Participants whose genetic test is abnormal with the mutation that may cause cancer will be assigned to:
- The usual approach (Group 1) where you will contact your first-degree family members to recommend them to have genetic testing, or
- The provider-mediated approach (Group 2) where a study team member will contact your first-degree family members to recommend and assist scheduling their genetic testing.
Principal Investigator

Additional Information
Address: 1500 E 2nd St. Reno, NV 89502
General Research: 775-982-3646
Oncology Research: 775-982-5050
Email: Renown-CRD@renown.org
Complete Study Details: https://clinicaltrials.gov/study/NCT07143487
Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.